Concepedia

Christopher G. Levins

CG

Statistics

Publications

10

Citations

2.2K

H-Index

10

Active since

2003

Affiliations

Massachusetts Institute of Technology(Current)

Harvard–MIT Division of Health Sciences and Technology

Alnylam Pharmaceuticals (United States)

Harvard University

Technion – Israel Institute of Technology

Christopher G. Levins is an author at Massachusetts Institute of Technology specializing in pharmacy, drug delivery, and gene delivery.

Publications per year

2003–2014

10

Publications

10

Lipid-like materials for low-dose, in vivo gene silencing

Kevin T. Love, Kerry P. Mahon, Christopher G. Levins et al. · Proceedings of the National Academy of Sciences · 2010 · 965 citations · Full text

, , +17

In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight

James E. Dahlman, Carmen Barnes, Omar F. Khan et al. · Nature Nanotechnology · 2014 · 573 citations · Full text

, , +17

Combinatorial synthesis of chemically diverse core-shell nanoparticles for intracellular delivery

Daniel J. Siegwart, Kathryn A. Whitehead, Lutz Nuhn et al. · Proceedings of the National Academy of Sciences · 2011 · 201 citations · Full text

, , +17

The Scope and Mechanism of Phosphonium-Mediated S<sub>N</sub>Ar Reactions in Heterocyclic Amides and Ureas

Zhao‐Kui Wan, Sumrit Wacharasindhu, Christopher G. Levins et al. · The Journal of Organic Chemistry · 2007 · 113 citations

, , +9

Remotely Activated Protein-Producing Nanoparticles

Avi Schroeder, Michael S. Goldberg, Christian J. Kastrup et al. · Nano Letters · 2012 · 113 citations

, , +17

1–5 of 10